Article Correctness Is Author's Responsibility: Updated Report on Trends in Global PD-1/PD-L1 Immunotherapy Clinical Development from the Cancer Research Institute Published in Nature Reviews Drug Discovery

Latest analysis of the global PD-1/PD-L1 immunotherapy clinical development pipeline reveals dramatic growth over past two years in number of trials, drug combinations, and drug targets, but lower patient recruitment rates in the U.S. compared to China.

read more

Article Correctness Is Author's Responsibility: Cancer Research Institute Announces 2019 Recipients of Its Top Scientific and Philanthropic Awards Honoring Discovery, Service in Advancing Cancer Immunology and Immunotherapy Research

The Cancer Research Institute (CRI), a nonprofit organization dedicated to advancing the discovery and development of powerful immunotherapies for all forms of cancer, has announced the 2019 recipients of its highest scientific and philanthropic awards…

read more

Article Correctness Is Author's Responsibility: Three Scientists to Receive Top Honors From the Cancer Research Institute for Outstanding Contributions to Cancer Immunology and Immunotherapy

The Cancer Research Institute will bestow its highest honors on three scientists who have made fundamental contributions to the fields of immunology and cancer immunotherapy at its annual taking place on Thursday, October 25, 2018, at The Metropolitan …

read more

Article Correctness Is Author's Responsibility: Biotechnology Company Regeneron and Journalist and Filmmaker Perri Peltz to Receive the 2018 Oliver R. Grace Award for Distinguished Service in Advancing Cancer Research

he Cancer Research Institute will honor biotechnology company Regeneron, and journalist and filmmaker Perri Peltz with the 2018 Oliver R. Grace Award for Distinguished Service in Advancing Cancer Research at its annual gala taking place on Thursday, Oc…

read more